While gastrointestinal issues are common side effects, the biggest setbacks happen when the patient stops taking a GLP-1
Both are being discussed and in some cases sold online, raising serious patient safety concerns
It offers strong business opportunities for pharma franchise partners, distributors, stockists, and wholesalers looking to expand their cardiovascular and specialty care portfolio
@chiarthritis Replying to @Lupita_011235 #glp1 treatments like #semaglutide have a role in #autoimmune patients, but they are not meant to replace your current autoimmune medications for #inflammation Caution with Using GLP-1 Agonists in Place of Autoimmune Disease Modifying Treatments Since discussing the use of GLP-1 agonists for improving metabolic health in autoimmune patients, some have asked whether GLP-1 medications can replace their disease-modifying treatments
Potential Mechanisms for Blood Clot Formation with Wegovy (Semaglutide): Inflammation: Some GLP-1 receptor agonists, including semaglutide, may cause inflammation in blood vessels, making them more susceptible to clot formation